# AstraNu

> Nokia Bell Labs photonics spinout building a compact swept-source optical coherence tomography imaging module for medical-device manufacturers.

## Why it is interesting

$3.5M Seed funding supports partner validation and manufacturing preparation. The chip-scale imaging engine is not yet a widely shipped or independently clinically validated finished medical device.

## Profile

- **Latest funding:** Seed — $3.5M (November 17, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $3.5M
- **Stage:** seed
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-11-18
- **Latest funding investors:** Celesta Capital, New Jersey Innovation Evergreen Fund

## Key facts

- $3.5M Seed led by Celesta Capital with New Jersey Innovation Evergreen Fund participation, announced November 17, 2026.
- Nokia Bell Labs spinout founded May 2025; chip-scale swept-source OCT is currently in partner validation.
- Volume module sales targeted for mid-to-late 2027, not established 2026 sales.

## Funding history

- Seed · $3.5M · November 17, 2026
  Source: https://www.prnewswire.com/news-releases/astranu-closes-3-5-million-seed-round-led-by-celesta-capital-to-commercialize-chip-scale-optical-imaging-engine-302941615.html

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** November 18, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/astranu-oct-imaging
